• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ibrutinib and invasive fungal infections: the known, the unknown and the known unknowns.

作者信息

Reynolds Gemma, Slavin Monica, Teh Benjamin W

机构信息

Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia.

National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia.

出版信息

Leuk Lymphoma. 2020 Oct;61(10):2292-2294. doi: 10.1080/10428194.2020.1797017. Epub 2020 Jul 23.

DOI:10.1080/10428194.2020.1797017
PMID:32701043
Abstract
摘要

相似文献

1
Ibrutinib and invasive fungal infections: the known, the unknown and the known unknowns.伊布替尼与侵袭性真菌感染：已知、未知与已知的未知情况
Leuk Lymphoma. 2020 Oct;61(10):2292-2294. doi: 10.1080/10428194.2020.1797017. Epub 2020 Jul 23.
2
High rates of proven invasive fungal disease with the use of ibrutinib monotherapy for relapsed or refractory chronic lymphocytic leukemia.在使用依鲁替尼单药治疗复发或难治性慢性淋巴细胞白血病时，侵袭性真菌病确诊率较高。
Leuk Lymphoma. 2019 Jun;60(6):1572-1575. doi: 10.1080/10428194.2018.1543884. Epub 2019 Jan 11.
3
Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer.接受伊布替尼治疗淋巴癌患者的严重感染。
Clin Infect Dis. 2018 Aug 16;67(5):687-692. doi: 10.1093/cid/ciy175.
4
Disseminated mucormycosis due to Lichtheimia corymbifera during ibrutinib treatment for relapsed chronic lymphocytic leukaemia: a case report.伊布替尼治疗复发慢性淋巴细胞白血病期间因伞枝犁头霉引起的播散性毛霉病：一例报告
Clin Microbiol Infect. 2019 Feb;25(2):261-263. doi: 10.1016/j.cmi.2018.10.004. Epub 2018 Oct 26.
5
Ibrutinib-associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: An observational study.伊布替尼相关侵袭性真菌病在慢性淋巴细胞白血病和非霍奇金淋巴瘤患者中的观察性研究。
Mycoses. 2019 Dec;62(12):1140-1147. doi: 10.1111/myc.13001. Epub 2019 Oct 22.
6
Incidence and characterization of fungal infections in chronic lymphocytic leukemia patients receiving ibrutinib.接受依鲁替尼治疗的慢性淋巴细胞白血病患者真菌感染的发生率及特征
Leuk Lymphoma. 2020 Oct;61(10):2488-2491. doi: 10.1080/10428194.2020.1775215. Epub 2020 Jun 12.
7
The infectious thyroid nodule: a case report of mucormycosis associated with ibrutinib therapy.感染性甲状腺结节：一例与伊布替尼治疗相关的毛霉菌病病例报告。
J Otolaryngol Head Neck Surg. 2019 Oct 16;48(1):49. doi: 10.1186/s40463-019-0376-1.
8
Atypical primary cutaneous cryptococcosis during ibrutinib therapy for chronic lymphocytic leukemia.伊布替尼治疗慢性淋巴细胞白血病期间发生的非典型原发性皮肤隐球菌病。
Ann Hematol. 2019 Dec;98(12):2847-2849. doi: 10.1007/s00277-019-03837-1. Epub 2019 Nov 18.
9
Cryptococcal infections in two patients receiving ibrutinib therapy for chronic lymphocytic leukemia.两名接受依鲁替尼治疗慢性淋巴细胞白血病的患者发生隐球菌感染。
J Oncol Pharm Pract. 2019 Apr;25(3):710-714. doi: 10.1177/1078155217752078. Epub 2018 Jan 17.
10
Cerebral aspergillosis in a patient on ibrutinib therapy-A predisposition not to overlook.接受依鲁替尼治疗的患者发生脑曲霉病——一种不容忽视的易患因素。
J Oncol Pharm Pract. 2019 Sep;25(6):1486-1490. doi: 10.1177/1078155218788717. Epub 2018 Jul 25.

引用本文的文献

1
Scedosporium Brain Abscess: A Rare and Fatal Drawback of Bruton Tyrosine Kinase Inhibitor Therapy.帚霉属脑脓肿：布鲁顿酪氨酸激酶抑制剂治疗的一种罕见且致命的弊端
J Hematol. 2024 Oct;13(5):224-228. doi: 10.14740/jh1263. Epub 2024 Oct 21.
2
[Analysis of infection in B-cell lymphoma patients treated with BTK inhibitors].[布鲁顿酪氨酸激酶（BTK）抑制剂治疗B细胞淋巴瘤患者的感染分析]
Zhonghua Xue Ye Xue Za Zhi. 2023 Jul 14;44(7):582-586. doi: 10.3760/cma.j.issn.0253-2727.2023.07.011.
3
Managing the Risk of Infection in Chronic Lymphocytic Leukemia in the Era of New Therapies.
管理新型疗法时代慢性淋巴细胞白血病的感染风险。
Curr Oncol Rep. 2022 Aug;24(8):1003-1014. doi: 10.1007/s11912-022-01261-9. Epub 2022 Apr 2.
4
BTK Inhibitors Impair Platelet-Mediated Antifungal Activity.BTK 抑制剂会损害血小板介导的抗真菌活性。
Cells. 2022 Mar 16;11(6):1003. doi: 10.3390/cells11061003.
5
Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real-world study.新型靶向药物治疗的淋巴增殖性疾病患者的严重感染：一项多中心真实世界研究。
Cancer Med. 2021 Nov;10(21):7629-7640. doi: 10.1002/cam4.4293. Epub 2021 Sep 23.